ConductScience.org, home

Paper18544439

New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Lee NY and 1 other. Semin Oncol, 2008. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. Papers, record 18544439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18544439

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.
PubMed
Journal
Semin Oncol
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee NYNancy Y
2Le QTQuynh-Thu

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Cell HypoxiaMajor topic
Head and Neck NeoplasmsMajor topic
Radiotherapy, Intensity-ModulatedMajor topic
Advance Care Planning
Biomarkers
Forecasting
Humans
Treatment Outcome

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA067166NCI NIH HHSUnited StatesP01CA067166PubMed and NIHNIH RePORTER
R01 CA118582NCI NIH HHSUnited StatesR01CA118582PubMed and NIHNIH RePORTER
1 R01 CA118582-01NCI NIH HHSUnited StatesR01CA118582PubMed and NIHNIH RePORTER

Download CSV of grants

References132

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117390721Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers.Radiat Res2007https://conductscience.org/library/papers/17390721PubMed
211849800ARCON: experience in 215 patients with advanced head-and-neck cancer.Int J Radiat Oncol Biol Phys2002https://conductscience.org/library/papers/11849800PubMed
317028293Do erythropoietin receptors on cancer cells explain unexpected clinical findings?J Clin Oncol2006https://conductscience.org/library/papers/17028293PubMed
417493769Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17493769PubMed
517161557Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17161557PubMed
68996152Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.J Clin Oncol1997https://conductscience.org/library/papers/8996152PubMed
717523848Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.Radiat Res2007https://conductscience.org/library/papers/17523848PubMed
810749120
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Cancer Res2000https://conductscience.org/library/papers/10749120PubMed
911516874Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy.Int J Radiat Oncol Biol Phys2001https://conductscience.org/library/papers/11516874PubMed
1011439212Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland.Radiother Oncol2001https://conductscience.org/library/papers/11439212PubMed
1117606726Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.Clin Cancer Res2007https://conductscience.org/library/papers/17606726PubMed
1210691731Loss of PTEN facilitates HIF-1-mediated gene expression.Genes Dev2000https://conductscience.org/library/papers/10691731PubMed
1315590175Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.Int J Radiat Oncol Biol Phys2004https://conductscience.org/library/papers/15590175PubMed
1416358297Intensity-modulated radiation therapy in head and neck cancers: an update.Head Neck2007https://conductscience.org/library/papers/16358297PubMed
1510974465Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques.Int J Radiat Oncol Biol Phys2000https://conductscience.org/library/papers/10974465PubMed
1610766193Detection of hypoxia in human squamous cell carcinoma by EF5 binding.Cancer Res2000https://conductscience.org/library/papers/10766193PubMed
1717145527A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.Int J Radiat Oncol Biol Phys2006https://conductscience.org/library/papers/17145527PubMed
189510041
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Radiother Oncol1998https://conductscience.org/library/papers/9510041PubMed
19986241Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo.Cancer Res1976https://conductscience.org/library/papers/986241PubMed
2010640954Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.Cancer2000https://conductscience.org/library/papers/10640954PubMed

See all 132 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
40653801Clinical feasibility of atlas-based auto-segmentation for organ-at-risk contouring in head-and-neck radiotherapy.J Appl Clin Med Phys2025https://conductscience.org/library/papers/40653801PubMed
39144264Radiation induced brachial plexopathy in head and neck cancer patients treated with definitive radiotherapy and correlation with disease characteristics and dosimetric parameters.Rep Pract Oncol Radiother2024https://conductscience.org/library/papers/39144264PubMed
39136231Vocal Fold Medialization Procedures in Previously Radiated Patients: A Survey of Practice Patterns.Laryngoscope2025https://conductscience.org/library/papers/39136231PubMed
35910347The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.Front Pharmacol2022https://conductscience.org/library/papers/35910347PubMed
33632902Radiation therapy in head and neck cancer.Saudi Med J2021https://conductscience.org/library/papers/33632902PubMed
32084217The role of Glial cell derived neurotrophic factor in head and neck cancer.PLoS One2020https://conductscience.org/library/papers/32084217PubMed
29335337Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement.EMBO Mol Med2018https://conductscience.org/library/papers/29335337PubMed
28249612Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.Radiat Oncol2017https://conductscience.org/library/papers/28249612PubMed
25036711Neurotrophic factor GDNF promotes survival of salivary stem cells.J Clin Invest2014https://conductscience.org/library/papers/25036711PubMed
24829856Relationship between head and neck cancer therapy and some genetic endpoints.World J Clin Oncol2014https://conductscience.org/library/papers/24829856PubMed
24203760Final results of a phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma.Clin Transl Oncol2014https://conductscience.org/library/papers/24203760PubMed
23812668A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.Clin Cancer Res2013https://conductscience.org/library/papers/23812668PubMed
23188186Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.J Radiat Res2013https://conductscience.org/library/papers/23188186PubMed
22300574Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.Int J Radiat Oncol Biol Phys2012https://conductscience.org/library/papers/22300574PubMed
21998334A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo.Clin Cancer Res2011https://conductscience.org/library/papers/21998334PubMed
21838917Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma.Radiat Oncol2011https://conductscience.org/library/papers/21838917PubMed
20706842Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients.Eur Arch Otorhinolaryngol2011https://conductscience.org/library/papers/20706842PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18544439

GET https://conductscience.org/api/papers/v1/18544439/references?page=2